Literature DB >> 20663683

Primary arterial switch operation in children presenting late with d-transposition of great arteries and intact ventricular septum. When is it too late for a primary arterial switch operation?

Akshay Kumar Bisoi1, Pranav Sharma, Sandeep Chauhan, Srikrishna Modugula Reddy, Shambhunath Das, Anita Saxena, Shyam Sunder Kothari.   

Abstract

OBJECTIVE: The surgical management of infants older than 2 weeks with d-transposition of great arteries and intact ventricular septum (IVS) is a matter of debate. Some studies have presented good results of primary arterial switch operation (ASO) in these children. The aim of this study was to assess the surgical outcome of the primary ASO in children with d-transposition of great arteries and IVS presenting beyond 6 weeks of age.
METHODS: The clinical records of the children (more than 6 weeks age) with d-transposition of great arteries and IVS, who underwent primary ASO at our institute between January 2003 and June 2009 were reviewed. Left ventricular geometry and interventricular septal motion on the transthoracic cross-sectional echocardiogram were taken to assess the left ventricle preparedness.
RESULTS: Fifty-five children (age ranging from 42 days to 9 years) with d-transposition of great arteries and IVS underwent primary ASO. The mean cardiopulmonary bypass time was 94.7±21.3 min, while mean aortic cross-clamp time was 53.2±8.1 min. Seven (13%) of these children died during their hospital stay. The children who had severely regressed left ventricle (banana-shaped left ventricular geometry) were operated with integrated extra corporeal membrane oxygenation-cardiopulmonary bypass (ECMO-CPB) circuit for left ventricular re-training. The children with regressed left ventricle required longer ventilatory time and inotropic support. Recovery of left ventricular geometry has taken 1-6 months depending on age at surgery.
CONCLUSIONS: The children older than 6 weeks with d-transposition of great arteries and IVS can benefit from primary ASO with acceptable results. However, the need for mechanical support in some of the older patients may limit the widespread adoption of such a strategy.
Copyright © 2010 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20663683     DOI: 10.1016/j.ejcts.2010.03.037

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  7 in total

1.  Perioperative care of a child with transposition of the great arteries.

Authors:  Angela Lorts; Catherine D Krawczeski
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-10

Review 2.  Consensus on timing of intervention for common congenital heart diseases: part II - cyanotic heart defects.

Authors:  P Syamasundar Rao
Journal:  Indian J Pediatr       Date:  2013-05-03       Impact factor: 1.967

3.  Ductal recanalization and stenting for late presenters with TGA intact ventricular septum.

Authors:  Shyam S Kothari; Sivasubramanian Ramakrishnan; Nagendra Boopathy Senguttuvan; Saurabh Kumar Gupta; Akshay K Bisoi
Journal:  Ann Pediatr Cardiol       Date:  2011-07

Review 4.  Surgery for transposition of great arteries: A historical perspective.

Authors:  Supreet P Marathe; Sachin Talwar
Journal:  Ann Pediatr Cardiol       Date:  2015 May-Aug

5.  Lactate clearance for initiating and weaning off extracorporeal membrane oxygenation in a child with regressed left ventricle after arterial switch operation.

Authors:  Sarvesh Pal Singh; Sandeep Chauhan; A K Bisoi; Manoj Sahoo
Journal:  Ann Card Anaesth       Date:  2016 Jan-Mar

6.  D-Transposition of great arteries with severe calcific aortic stenosis in an adult patient: a rare presentation.

Authors:  Prashant Mishra; Kuntal Surana; Chaitanya Raut; Vijay Shewale
Journal:  Kardiochir Torakochirurgia Pol       Date:  2022-03-24

7.  Role of phenoxybenzamine in perioperative clinical practice.

Authors:  Das Sambhunath; Kumar Pankaj; Kiran Usha
Journal:  Ann Card Anaesth       Date:  2015 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.